Johns Hopkins logo

Health Newsfeed

OSTEOPOROSIS MEDS

ANCHOR LEAD: TURNS OUT THERE MAY BE A DOWNSIDE FOR MEDICATIONS USED FOR OSTEOPOROSIS, ELIZABETH TRACEY REPORTS

Somewhat disturbing information is starting to emerge related to bisphosphonates, a class of medications used to prevent and treat osteoporosis.  Michelle Bellantoni, a geriatrics expert at Johns Hopkins, explains.

BELLANTONI: As these drugs have been used in clinical practice now greater than 10 years we’re beginning to see long term risks, in particular bone that may become fragile over time.  Some feel this is related to the fact that individuals take the medicines but do not continue the calcium and vitamin D, the very important nutrients for bone health.  And so what we’re left with is bone proteins that remain in place but not very strong bone without the calcium.     :26

Bellantoni says people who are taking these medications may need periodic assessments of bone strength to determine whether changes to the drug and supplement regimen are needed.  At Johns Hopkins, I’m Elizabeth Tracey.

 



Search Health NewsFeed

-----------------------------------------
Health NewsFeed Home | Hopkins Medicine Home